Join
Live feed
·
INSIDERFilingvia Quantisnow
Aadi Bioscience Inc. logo

CHIEF EXECUTIVE OFFICER Lennon David James converted options into 16,250 shares and sold $13,372 worth of shares (5,690 units at $2.35), increasing direct ownership by 46% to 33,429 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AADI (Aadi Bioscience Inc.) and more on Quantisnow.